| Gene symbol | SLC5A5 | Synonyms | NIS, TDH1 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19p13.11 | dbXrefs | |
| Description | solute carrier family 5 member 5 | ||||
| GTO ID | GTC1306 |
| Trial ID | NCT00788307 |
| Disease | Prostate Cancer |
| Altered gene | NIS |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | AdV5-CMV-NIS |
| Co-treatment | liothyronine sodium|iodine I 131 |
| Phase | Phase1 |
| Recruitment status | Terminated |
| Title | Phase I Trial of In Situ Gene Therapy for Locally Recurrent Prostate Cancer Following Radiation Therapy Failure Using Sodium/Iodide Symporter and Radioiodine |
| Year | 2008 |
| Country | United States |
| Company sponsor | Mayo Clinic |
| Other ID(s) | MC0252|P30CA015083|MC0252|06-009392|NCI-2009-01195 |
| Vector information | |||||||||||
|
|||||||||||
| Cohort 1 | |||||||
|
|||||||